Pharmafile Logo
Pharmafocus logo
Advanced Search

Aptuit

Showing 7 posts of 7 posts found.

AMRI image

AMRI buys two Aptuit facilities

January 13, 2015
Manufacturing and Production AMRI, Aptuit, cedarburg, glasgow, oso

Contract research and manufacturing firm AMRI has acquired two businesses from pharmaceutical services company Aptuit in a $60 million deal. …

News
jonathan_goldman_aptuit

Aptuit hires chief executive from ICON

December 3, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Aptuit, ICON, goldman

Drug development services firm Aptuit has named Dr Jonathan Goldman as its chief executive, completing the company’s senior management leadership …

Appointment
Aptuit image

MHRA wins data scam case

March 13, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Aptuit, MHRA, data

An ex-employee of research organisation Aptuit has been found guilty of changing pre-clinical trial data as part of a bid to …

News

Contract research news in brief

February 11, 2013
Research and Development Antabio, Aptuit, Argenta, Cross Country Healthcare, ICON, PPD, Quintiles, Verum.de

Icon offers $52m for CCH’s clinical services division, plus updates from PPD, Aptuit, Argenta, Quintiles and Verum.de.

News

Catalent to buy Aptuit and claim number two spot in clinical supply

August 30, 2011
Manufacturing and Production Aptuit, Catalent, manufacturing and production news

Catalent Pharma Solutions has agreed to purchase the clinical trial supply business of Aptuit in a $410 million deal which …

News

Scottish First Minister seeks talks with Aptuit over plant closures

December 21, 2010
Manufacturing and Production Aptuit, Scotland, manufacturing facilities, pharma manufacturing

US contract manufacturing and drug development company Aptuit says it may shut down two facilities in Lothian, Scotland, because demand …

News
GSK workers protest

Aptuit deal saves GSK’s R&D unit in Verona

July 5, 2010
Manufacturing and Production, Research and Development Aptuit, GlaxoSmithKline, Italy

GlaxoSmithKline has sold off its medicines research facility in Verona, Italy, to contract research and manufacturing service group Aptuit in …

News

Latest content

Eli Lilly acquires new manufacturing facility from Nexus Pharmaceuticals

April 24, 2024

GSK’s Jemperli accepted for FDA review for endometrial cancer treatment

April 24, 2024

Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia

April 23, 2024

FDA approves ImmunityBio’s Anktiva bladder cancer treatment

April 23, 2024

EC approves Pfizer’s Emblaveo for multidrug-resistant infection treatment

April 22, 2024